Similar articles

• Therapeutic milestones. Novantrone (mitozantrone).

  Cotter FE. Cotter FE. Br J Clin Pract. 1988 May;42(5):207-9. Br J Clin Pract. 1988. PMID: 3063315 Review. No abstract available.
• [Evaluation of mitoxantrone in 1989].

  Coiffier B. Coiffier B. Pathol Biol (Paris). 1989 Nov;37(9):1007-8. Pathol Biol (Paris). 1989. PMID: 2691971 Clinical Trial. French. No abstract available.
• An overview of mitozantrone.

  Birchall LA, Bailey NP, Blackledge GR. Birchall LA, et al. Br J Clin Pract. 1991 Autumn;45(3):208-11. Br J Clin Pract. 1991. PMID: 1805919 Review. No abstract available.
• [Introduction of a new anticancer drug, novantrone].

  Tsukagoshi S. Tsukagoshi S. Gan To Kagaku Ryoho. 1987 Nov;14(11):3163-72. Gan To Kagaku Ryoho. 1987. PMID: 3314715 Clinical Trial. Japanese.
• Evolving clinical strategies: innovative approaches to the use of mitoxantrone--introduction.

  Powles TJ. Powles TJ. Eur J Cancer Care (Engl). 1997 Dec;6(4 Suppl):1-3. doi: 10.1111/j.1365-2354.1997.tb00317.x. Eur J Cancer Care (Engl). 1997. PMID: 9460335 Review.